• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

The regulation of cell proliferation in Tuberous Sclerosis

The regulation of cell proliferation in Tuberous Sclerosis

Markus Hengstschläger (ORCID: )
  • Grant DOI 10.55776/P13127
  • Funding program Principal Investigator Projects
  • Status ended
  • Funding amount € 107,265

Disciplines

Biology (80%); Medical-Theoretical Sciences, Pharmacy (20%)

Keywords

    TUBEROUS SCLEROSIS, TRANSFORMATION, CELL CYCLE, GTPASE ACCELERATING PROTEIN, NEURONAL DIFFERENTIATION

Abstract

Tuberous sclerosis (TSC) is an autosomal dominant disease with an estimated prevelance of about 1 in 6000. This disease is characterized by mental retardation, epilepsy, and mostly non-malignant tumors of the skin, retina, kidney, and brain. Linkage studies in families with TSC show that about 50% are associated with a loss of functional TSCI gene, while TSC2 is implicated in the remainder. TSC2 has been cloned in 1993. Since then it has been shown that the TSC2 gene product, tuberin, has GTPase accelerating protein (GAP) activity against Rapla and Rab5. Recent data of our laboratory demonstrated that tuberin plays an important role in the regulation of the eukaryotic cell cycle. Currently, a more detailed understanding of the role of TSC2 in cell cycle control and transformation is missing. In the course of the submitted project we want to detaily investigate the mechanism of the effects of modulated tuberin expression on cell cycle control and anchorage-independent growth and investigate whether its GAP activity is necessary for these effects. Other results of our laboratory showed that tuberin is an essential regulator of the process of neuronal differentiation. As a logical consequence, we will now analyse the role of tuberin in the development of neuroectodermal tumors and the role of tuberin`s GAP activities in mediating these effects. Half a year ago, TSCI has been cloned. So far no biochemical or biological properties of its gene product, hamartin, have been reported. Since the clinical features of TSCI- and TSC2-associated TSC are identical, it is likely that tuberin and hamartin participate in the same pathways of cellular growth/differentiation control. Accordingly, we will analyse the effects of modulated hamartin expression on the regulation of cell cycle control, anchorage-independent growth and neuronal differentiation. The mechanisms of cellular effects upon modulated hamartin expression will detaily be investigated. Furthermore, to get more insights into the functions of hamartin we will search for hamartin-interacting proteins using the two hybrid screen. lt is the hope of tuberous sclerosis patients and investigators alike that a better understanding of the cellular role of the two proteins, tuberin and hamartin, will allow the development of specific therapies to both prevent and treat the manifestations of TSC. The submitted project was designed with an eye toward these goals.

Research institution(s)
  • Medizinische Universität Wien - 100%

Research Output

  • 279 Citations
  • 2 Publications
Publications
  • 2020
    Title Atmospheric Escape Processes and Planetary Atmospheric Evolution
    DOI 10.1029/2019ja027639
    Type Journal Article
    Author Gronoff G
    Journal Journal of Geophysical Research: Space Physics
    Link Publication
  • 1998
    Title Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2
    DOI 10.1073/pnas.95.26.15653
    Type Journal Article
    Author Soucek T
    Journal Proceedings of the National Academy of Sciences
    Pages 15653-15658
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF